Company:  URIGEN PHARMACEUTICALS, I ...
Form Type:  8-K
Filing Date:  9/12/2012 
CIK:  0000932352 
Address:  501 SILVERSIDE ROAD PMB#95 
City, State, Zip:  WILMINGTON, Delaware 19809 
Telephone:  (925) 280-2861 
Fiscal Year:  06/30 
Description of Business
This report contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements include, without limitation, statements containing the words �believes,� �anticipates,� �expects,� �intends,� �projects,� �will,� and other words of similar import or the negative of those terms or expressions. Forward-looking statements in this report include, but are not limited to, expectations of future levels of research and development spending, general and administrative spending, levels of capital expenditures and operating results, sufficiency of our capital resources, our intention to pursue and consummate strategic opportunities available to us, including sales of certain of our assets.
Register for EDGAR Pro and access this filing in:     
  FORM 8-K
    SECTION 1 BUSINESS AND OPERATIONS
      Item 1.01. Entry into a Material Definitive Agreement
    SIGNATURE
BROKERAGE PARTNERS